The Globe and Mail reports in its Thursday, Nov. 23, edition that RBC Capital Markets analyst Maurice Choy has reaffirmed his "outperform" recommendation for TransAlta. The Globe's David Leeder writes in the Eye On Equities column that Mr. Choy trimmed his share target back by a loonie to $15. Analysts on average target the shares at $15.67. Mr. Choy says in a note: "Besides a weaker-than-expected 2024 guidance, we believe the Investor Day's negative share price reaction was partly due to the perception that some capital c/should have been allocated to share buybacks given how the shares are trading below the intrinsic values estimated by management and many investors. However, as multi-year growth rarely happens linearly, we believe TransAlta will exhibit flexibility in its capital allocation (including by buying back its shares) in the near-term if it does not identify opportunities that collectively have returns/yields that are more comparable (if not superior to) those implied by its share price." The Globe reported on Oct. 11 that CIBC World Markets analyst Mark Jarvi was keeping his "outperformer" call on TransAlta intact. The shares could then be had for $11.74.